- Home
- RPRX vs ERIE Comparison
RPRX vs ERIE Comparison
Compare RPRX & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ERIE
- Stock Information
- Founded
- RPRX 1996
- ERIE 1925
- Country
- RPRX United States
- ERIE United States
- Employees
- RPRX N/A
- ERIE N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ERIE Specialty Insurers
- Sector
- RPRX Health Care
- ERIE Finance
- Exchange
- RPRX Nasdaq
- ERIE Nasdaq
- Market Cap
- RPRX 16.2B
- ERIE 19.2B
- IPO Year
- RPRX 2020
- ERIE 1995
- Fundamental
- Price
- RPRX $39.54
- ERIE $287.88
- Analyst Decision
- RPRX Strong Buy
- ERIE
- Analyst Count
- RPRX 3
- ERIE 0
- Target Price
- RPRX $46.00
- ERIE N/A
- AVG Volume (30 Days)
- RPRX 3.7M
- ERIE 158.5K
- Earning Date
- RPRX 11-05-2025
- ERIE 10-30-2025
- Dividend Yield
- RPRX 2.21%
- ERIE 1.90%
- EPS Growth
- RPRX N/A
- ERIE 15.90
- EPS
- RPRX 1.75
- ERIE 12.39
- Revenue
- RPRX $2,349,844,000.00
- ERIE $4,040,325,000.00
- Revenue This Year
- RPRX $36.16
- ERIE $10.96
- Revenue Next Year
- RPRX $2.04
- ERIE $8.12
- P/E Ratio
- RPRX $22.68
- ERIE $23.22
- Revenue Growth
- RPRX 3.70
- ERIE 9.53
- 52 Week Low
- RPRX $24.05
- ERIE $276.91
- 52 Week High
- RPRX $41.24
- ERIE $456.93
- Technical
- Relative Strength Index (RSI)
- RPRX 61.44
- ERIE 39.35
- Support Level
- RPRX $38.39
- ERIE $276.91
- Resistance Level
- RPRX $41.24
- ERIE $290.88
- Average True Range (ATR)
- RPRX 1.23
- ERIE 10.17
- MACD
- RPRX 0.15
- ERIE -1.30
- Stochastic Oscillator
- RPRX 67.51
- ERIE 19.67
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ERIE Erie Indemnity Company
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.